Hollings Cancer Center Varenicline Sampling Study

计划入组 99 人 · 首次发布于 2018 年 11 月 15 日

Hypofractionated IMRT With Concurrent Chemotherapy in Muscle-invasive Bladder Cancer (HIRACUM)

计划入组 53 人 · 首次发布于 2022 年 7 月 12 日

Teens Taking Charge: Managing Cancer Online

计划入组 73 人 · 首次发布于 2014 年 11 月 24 日

Fecal Microbiota Transplantation（German Cancer Research Center）

Neoantigen-Targeted ppDC Vaccine(Uclas Jonsson Comprehensive Cancer Center)

Human papillomavirus tumor antigen vaccine (Vanderbilt University/Ingram Cancer Center)

CENTER WEST CANCER

United States

Providence Cancer Center

NATIONAL CANCER CENTER

Japan

MUSC Hollings Cancer Center Launches AUTOMAIN Trial Testing Repurposed Drugs for Recurrent Ovarian Cancer

MUSC Researchers Develop Novel Antibody Targeting SFRP2 to Combat Triple-Negative Breast Cancer Resistance

Nationwide Study Reveals Critical Gaps in HPV Cancer Awareness, Particularly in Midwest and South